Yu-Nien (Tom) Sun serves as the Vice President of Strategic Consulting Services at Simulations Plus, Inc., where he leverages over two decades of extensive experience in translational pharmacokinetics/pharmacodynamics (PK/PD) research and clinical pharmacology. His role is pivotal in providing innovative solutions that integrate cutting-edge scientific...
Yu-Nien (Tom) Sun serves as the Vice President of Strategic Consulting Services at Simulations Plus, Inc., where he leverages over two decades of extensive experience in translational pharmacokinetics/pharmacodynamics (PK/PD) research and clinical pharmacology. His role is pivotal in providing innovative solutions that integrate cutting-edge scientific methods and technologies in Quantitative Clinical Pharmacology. Tom’s expertise spans a diverse range of therapeutic areas, including small molecules, biologics, and CAR-T therapies, making him a sought-after consultant for biotechnology and pharmaceutical companies navigating complex regulatory submissions and product registrations.
At Simulations Plus, Tom is at the forefront of key projects that aim to enhance model-based drug development. He leads initiatives that focus on the application of advanced modeling and simulation techniques to optimize drug discovery and development processes. His strategic vision not only supports the growth of the consulting group but also fosters cross-functional collaboration, ensuring that clinical pharmacology principles are seamlessly integrated into the drug development lifecycle.
Tom’s leadership is characterized by his commitment to advancing the field of clinical pharmacology through innovative consulting services. He has authored over 40 peer-reviewed articles and book chapters, contributing significantly to the body of knowledge in pharmacodynamics and translational medicine. His ability to synthesize complex scientific concepts into actionable insights empowers clients to make informed decisions that drive successful outcomes in drug development. With a strong foundation in pharmaceutics and clinical research, Tom Sun continues to shape the future of pharmacometrics, ensuring that clients are equipped with the tools and strategies necessary to thrive in a competitive landscape.
